| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | U8I57RC739 |
| InChI Key | PNHFDVSKDSLUFH-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C23H27N3O4 |
| Molecular Weight | 409.49 |
| AlogP | 3.76 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 97.47 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 30.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Peroxisome proliferator-activated receptor alpha agonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group C
Nuclear hormone receptor subfamily 1 group C member 1
|
42-42 | 23.99-24 | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group C
Nuclear hormone receptor subfamily 1 group C member 2
|
- | 3800-3801.89 | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group C
Nuclear hormone receptor subfamily 1 group C member 3
|
- | 6500-6501.3 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Metabolic Syndrome | 2 | D024821 | ClinicalTrials |
| Hypertension | 2 | D006973 | ClinicalTrials |
| Hypercholesterolemia | 2 | D006937 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL424133 |
| DrugBank | DB12988 |
| FDA SRS | U8I57RC739 |
| Guide to Pharmacology | 2658 |
| PubChem | 9909438 |
| SureChEMBL | SCHEMBL2669568 |
| ZINC | ZINC000000595076 |